Johnson Financial Group Inc (Wisconsin)’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-824	Closed	-$20.7K	–	664
2022 Q4	$20.7K	Buy	+824	New	+$22.1K	﹤0.01%	434

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s IDNA Position: Q1 2023 in Review

Johnson Financial Group Inc (Wisconsin) sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2023, closing a stake of 824 shares — an estimated $20.7K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in IDNA in Q4 2022 and held it in 1 quarter. The position peaked at $20.7K in Q4 2022. 75 funds tracked by Wall St. Rank hold IDNA as of Q1 2023.

Johnson Financial Group Inc (Wisconsin) reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2023 after selling out during the quarter.
Johnson Financial Group Inc (Wisconsin) sold 824 iShares Genomics Immunology and Healthcare ETF shares in Q1 2023, an estimated $20.7K.
Johnson Financial Group Inc (Wisconsin) first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2022 and held it in 1 quarter.
Johnson Financial Group Inc (Wisconsin)'s iShares Genomics Immunology and Healthcare ETF position peaked at $20.7K in Q4 2022.
75 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2023.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2023, filed 12 May 2023.